Shandong Bausch & Lomb Freda Pharmaceutical

Shandong Bausch & Lomb Freda Pharmaceutical is a leading Chinese pharmaceutical company specializing in ophthalmic and orthopedic products. Established in 1991 as a joint venture between Bausch + Lomb and the Shandong Freda Pharmaceutical Group, the company has become a dominant player in the Chinese eye care market. It is particularly renowned for its expertise in sodium hyaluronate technology, producing a variety of eye drops and intra-articular injections. The company's portfolio includes household brands such as Runshu and Runjie, addressing conditions like dry eye, glaucoma, and ocular inflammation. With state-of-the-art manufacturing facilities in Jinan, the company adheres to international GMP standards to supply high-quality treatments across China. As a key part of Bausch + Lomb's global operations, it serves as a critical manufacturing and commercial hub for the Asia-Pacific region.